Drayton Wise

Drayton Wise

Chief Commercial OfficeratINSMED· In proxies 2022–2024

Pay in FY2024INSMED stock +122.8% the same year

Drayton Wise was paid $4.1M in FY2024 (Dec). INSMED stock rose 122.8% that year.

Pay$100 in the stock at the end of FY21 → $163
Pay is from the Summary Compensation Table of each INSMED proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. INSMEDPublic company · 4 yr
    • Chief Commercial Officer2022 – Present · 4 yrStock in role +249%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?